MarketPulse

analyst coverage

6 articles
The Motley FoolThe Motley Fool··Eric Volkman

Celcuity Surges on Bullish Cancer Drug Outlook as Analyst Initiates Coverage

Celcuity rises 4% after Citizens initiates 'market outperform' coverage with $150 price target, citing gedatolisib's breast cancer approval potential within two months and multi-indication opportunity.
CELCFDA approvalbiotech
The Motley FoolThe Motley Fool··Keith Noonan

Cohu Stock Surges on AI Chip Boom, B. Riley Lifts Price Target to $50

Cohu surges 7.22% after B. Riley raises price target from $41 to $50, citing strong wafer-fab demand and AI-driven semiconductor tailwinds.
COHUartificial intelligencememory chips
BenzingaBenzinga··Erica Kollmann

Rare Earth Supply War Heats Up: USAR's $2.8B Serra Verde Deal Reshapes Global Competition

USA Rare Earth acquires Brazilian miner Serra Verde for $2.8B, diversifying rare earth supply away from Asia. Stocks rally on supply chain independence hopes.
MPUSARsupply chainM&A
The Motley FoolThe Motley Fool··Scott Levine

Nebius Stock Soars 21% on AI21 Labs Deal Speculation and Bullish Analyst Call

Nebius Group shares jumped 21.1% on acquisition speculation and analyst coverage, but trade at an extreme 896x operating cash flow valuation.
NBISacquisitionvaluation
BenzingaBenzinga··Prnewswire

Benchmark Initiates Coverage of $FRMM With Speculative Buy, $5 Price Target

Benchmark initiates $FRMM coverage with Speculative Buy rating and $5.00 price target, citing Forum's positioning in institutional real-world asset tokenization on Ethereum Layer-2 networks.
FRMMprice targetdigital assets
BenzingaBenzinga··Vandana Singh

BridgeBio Surges on Rare-Disease Momentum as Analyst Sees $93 Upside

BridgeBio Pharma jumps 12.6% after William Blair initiates coverage with Outperform rating, citing accelerating product launches and robust rare-disease pipeline.
PFEBBIOBMRNALNYregulatory approvaldrug development